: Р 177(3): 1087-94. 4661-9.Р60 Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, 74 Holzer AK, Manorek GH, Howell SB. Contribution of the major Р Mecklin JP, et al. Clues to the pathogenesis of familial colorectal copper influx transporter CTR1 to the cellular accumulation of Р cancer. Science 1993; 260(5109): 812-6. cisplatin, carboplatin, and oxaliplatin. Mol Pharmacol 2006; Р61 Gnoni A, Russo A, Silvestris N, Maiello E, a A, Marech 70(4): 1390-4.Р I, et al. ic and metabolism determinants of 75 Arnould S, Hennebelle I, Canal P, Bugat R, Guichard S. Cellular Р fluoropyrimidines and oxaliplatin activity in treatment of determinants of oxaliplatin sensitivity in colon cancer cell lines. Р colorectal patients. Curr Drug Metab 2011; 12(10): 918-31. Eur J Cancer 2003; 39(1): 112-9.